Journal Basic Info

  • Impact Factor: 1.809**
  • H-Index: 6
  • ISSN: 2474-1655
  • DOI: 10.25107/2474-1655
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Pathology
  •  Respiratory Medicine
  •  Anesthesiology and Pain Medicine
  •  Nutrition and Food Science
  •  Obstetrics and Gynecology
  •  Chronic Disease
  •  Hepatitis
  •  Transplantation Medicine

Abstract

Citation: Ann Clin Case Rep. 2016;1(1):1104.DOI: 10.25107/2474-1655.1104

Pneumo-Enzymatic Vitreolysis for Resistant Vitreomacular Traction

Jorge G. Arroyo, Gina Yu, Rachel Tandias and Sushant Wagley

Department of Ophthalmology, Harvard Medical School, USA Hurley Medical Center, USA

*Correspondance to: Jorge G. Arroyo 

 PDF  Full Text Case Report | Open Access

Abstract:

Aim: Case report describing a patient with resistant vitreomacular traction (VMT) treated with an intravitreal injection of a potentially safer, lower dose of ocriplasmin and with a residual intravitreal gas bubble from pneumatic vitreolysis.Case Report: An 88-year-old man with symptomatic vitreomacular traction (VMT) was observed for 4 weeks without spontaneous release. Pneumatic vitreolysis (PV, intravitreal injection of expansile gas with intermittent face-down positioning [FDP]) was performed. Four weeks later, a 30% bubble was still present in the vitreous, vision remained 20/70, and he had improved but persistent VMT. One-half of the recommended therapeutic dose of ocriplasmin was injected intravitreally and the patient continued FDP. At one-week follow-up, the patient had improved vision of 20/40, associated with complete VMT release. He had no adverse events.Discussion: Resistant VMT can lead to significant foveal distortion and subsequent vision loss. Pneumatic vitreolysis appears to successfully relieve VMT in about 80% of cases, but in the 20% of cases that do not respond, typically invasive, surgical intervention is required. This report shows the efficacy of combining the mechanical forces of PV with the enzymatic fibrinolytic activity available in a potentially safer, lower dose of ocriplasmin to treat resistant VMT cases, non-invasively.Summary: For resistant vitreomacular traction, combining the mechanical force of an intravitreal injection of an expansile gas with a half-dose of ocriplasmin could provide an efficacious treatment option, without the risk of the toxic safety profile often associated with ocriplasmin.

Keywords:

Ocriplasmin; Posterior vitreous detachment; Traction

Cite the Article:

Arroyo JG, Yu G, Tandias R, Wagley S. Pneumo-Enzymatic Vitreolysis for Resistant Vitreomacular Traction. Ann Clin Case Rep. 2016; 1: 1104.

Search Our Journal

Journal Indexed In

Articles in PubMed

Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and other Naturally Occurring Compounds, Part I
 PubMed  PMC  PDF  Full Text
Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Empyema Caused by Streptococcus constellatus: A Case Report
 Abstract  PDF  Full Text
Acute Monocytic Leukemia Secondary to Angioimmunoblastic T-Cell Lymphoma: A Case Report and Literature Review
 Abstract  PDF  Full Text
View More...